InvestorsHub Logo
Post# of 252254
Next 10
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: masterlongevity post# 150443

Thursday, 10/11/2012 2:06:31 PM

Thursday, October 11, 2012 2:06:31 PM

Post# of 252254
I think bapineuzumab is out of the game and my guess is ADCS scientists await for the biomarkers data from solanezumab EXPEDITION trials and if correlate with cognitive/functional findings, it will be the one cause as you've said safety is very important here and solanezumab has more safety data which are good.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.